These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23811701)
41. Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience. Philippou P; Yap T; Chinegwundoh F Urol Int; 2012; 88(2):137-44. PubMed ID: 22285952 [TBL] [Abstract][Full Text] [Related]
42. Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review. Duijzentkunst DA; Peters M; van der Voort van Zyp JR; Moerland MA; van Vulpen M World J Urol; 2016 Nov; 34(11):1521-1531. PubMed ID: 27012712 [TBL] [Abstract][Full Text] [Related]
43. Understanding participation in a trial comparing cryotherapy and radiation treatment. Eng M; Taylor L; Verhoef M; Ernst S; Donnelly B Can J Urol; 2005 Apr; 12(2):2607-13. PubMed ID: 15877944 [TBL] [Abstract][Full Text] [Related]
48. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Muto S; Yoshii T; Saito K; Kamiyama Y; Ide H; Horie S Jpn J Clin Oncol; 2008 Mar; 38(3):192-9. PubMed ID: 18281309 [TBL] [Abstract][Full Text] [Related]
49. Achieving the 'bifecta' using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data. Spiess PE; Given RW; Jones JS BJU Int; 2012 Jul; 110(2):217-20. PubMed ID: 21992443 [TBL] [Abstract][Full Text] [Related]
50. [Prostate cancer treatments in Belgium]. Kaitouni MI; Roumeguère T Rev Med Brux; 2009 Sep; 30(4):270-8. PubMed ID: 19899373 [TBL] [Abstract][Full Text] [Related]
51. Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner? Parker WR; Montgomery JS; Wood DP Curr Opin Urol; 2009 May; 19(3):303-8. PubMed ID: 19300266 [TBL] [Abstract][Full Text] [Related]
52. Focal therapy for prostate cancer. Alternative treatment. Gómez-Veiga F; Martínez-Breijo S; Solsona-Narbón E; Hernández C; Ciudin A; Ribal MJ; Dickinson L; Moore C; Ahmed H; Rodríguez Antolín A; Breda A; Gaya J; Portela-Pereira P; Emberton M Actas Urol Esp; 2014 Sep; 38(7):465-75. PubMed ID: 24612733 [TBL] [Abstract][Full Text] [Related]
54. Prostate cancer recurrence after Focal Therapy: Treatment options. Hamid S; Guillaumier S; Shah T; Arya M; Ahmed HU Arch Esp Urol; 2016 Jul; 69(6):375-83. PubMed ID: 27416641 [TBL] [Abstract][Full Text] [Related]
55. Active surveillance failure for prostate cancer: does the delay in treatment increase the risk of urinary incontinence? Radomski L; Gani J; Trottier G; Finelli A Can J Urol; 2012 Jun; 19(3):6287-92. PubMed ID: 22704315 [TBL] [Abstract][Full Text] [Related]
56. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. Barocas DA; Cowan JE; Smith JA; Carroll PR; J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731 [TBL] [Abstract][Full Text] [Related]
57. Cystectomy and Urinary Diversion for the Management of a Devastated Lower Urinary Tract Following Prostatic Cryotherapy and/or Radiotherapy. Sack BS; Langenstroer P; Guralnick ML; Jacobsohn KM; O'Connor RC WMJ; 2016 Apr; 115(2):70-3. PubMed ID: 27197339 [TBL] [Abstract][Full Text] [Related]
58. Focal or subtotal therapy for early stage prostate cancer. Jones JS Curr Treat Options Oncol; 2007 Jun; 8(3):165-72. PubMed ID: 17701110 [TBL] [Abstract][Full Text] [Related]
59. Focal therapy for prostate cancer: recent advances and future directions. Wang A; O'Connor LP; Yerram NK; Nandanan N; Ahdoot M; Lebastchi AH; Gurram S; Chalfin H; Pinto PA Clin Adv Hematol Oncol; 2020 Feb; 18(2):116-125. PubMed ID: 32558805 [TBL] [Abstract][Full Text] [Related]
60. Low temperature plasma: a novel focal therapy for localized prostate cancer? Hirst AM; Frame FM; Maitland NJ; O'Connell D Biomed Res Int; 2014; 2014():878319. PubMed ID: 24738076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]